Weekly Wrap: How the Pandemic Has Changed the Math on Emergency Funds and College Savings
We recap the week on Morningstar.com and note the most popular stocks, funds, and exchange-traded funds.
|Editor's note: Read the latest on how the coronavirus is rattling the markets and what investors can do to navigate it.|
Why Become an ESG Investor?
The question is not rhetorical.
Stakeholder Votes Divided on Social Justice
Proxy voting reveals disagreement between the influential majority and smaller shareholders on diversity, equity, and inclusion issues.
529 College Savings Plans During the Pandemic
Here's how they've been performing and what college savers should be thinking about today.
How Can Advisors Help Clients Through Market Anxiety?
Our research explored three tactics for dissuading client fears about increased volatility.
The New Math on Emergency Funds
Don't eat that first potato chip.
Portfolio Planning and Personal Finance With Christine Benz
Ramit Sethi: 'Question What You’ve Been Told About Buying a House'
The author of the best-selling book, "I Will Teach You to Be Rich," on how homeownership fits into a financial plan.
Electricity Demand's COVID Comeback
Utilities should benefit as the U.S. economy electrifies.
What Is Gold Worth?
And do any other assets currently compare?
Our Ultimate Stock-Pickers' Top 10 High-Conviction Purchases
Several funds see value in basic materials and industrials.
There’s Still Gas in Ford’s Tank
The legendary pony takes on Tesla and aims for pole position on profitability.
Stock Analyst Updates
Astra and Oxford Report Strong COVID-19 Vaccine
Astra’s vaccine looks potentially easier to transport with only mild temperature requirements as compared with the other vaccines.
Regeneron Authorized to Use Antibody Cocktail
We're maintaining our $500 fair value estimate for the narrow-moat drug manufacturer.